The Center for Technology Licensing's (CTL) mission is to bring the University's scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster economic development within New York State and across the nation.
Licensing
CTL is industry's link to Cornell's broad range of innovative research that is available for licensing. Over the years, Cornell technologies have been licensed to industry partners all over the world in support of Cornell's land-grant mission and to develop these technologies and plant varieties into products and services for public good.
Available Cornell Technologies
- Promoting Bone Formation by Enhancing Skeletal Angiogenesis with the SLIT/ROBO Pathway
- Novel Method for the Generation, Expansion, and Maintenance of Type-1 Regulatory T Cells
- Engineered sphingosine 1-phosphate (S1P) chaperone protein compositions and methods for treating vascular and non-vascular diseases and conditions
- Combination Cancer Therapy Involving the Chronic Use of Low Doses of ATR Signaling Inhibitors
- Raspberry 'Crimson Treasure'
- Multiplex Diagnostic Test for Equine Herpes Virus Type 1
Current Featured Technologies
- » White Wine Grape ‘Aromella’
- » Red Wine Grape ‘Arandell’
- » Tethered Enzyme Technology (TET™) Point-of-Care Testing for Brain Injuries
- » Reversible Small Molecule Immunoproteasome Inhibitors
- » Biomarkers for Predicting & Diagnosing Cancer/Metastasis
- » Accommodating Intraocular Lens & Conversion Plate
- » Generic Programmable Tag